These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28803993)

  • 1. Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth.
    Ahmad G; El Sadda R; Botchkina G; Ojima I; Egan J; Amiji M
    Cancer Lett; 2017 Oct; 406():71-80. PubMed ID: 28803993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and Pharmacokinetic Evaluations of a Novel Taxoid DHA-SBT-1214 in an Oil-in-Water Nanoemulsion Formulation in Naïve and Tumor-Bearing Mice.
    Ahmad G; Gattacecca F; El Sadda R; Botchkina G; Ojima I; Egan J; Amiji M
    Pharm Res; 2018 Mar; 35(4):91. PubMed ID: 29520477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.
    Botchkina GI; Zuniga ES; Rowehl RH; Park R; Bhalla R; Bialkowska AB; Johnson F; Golub LM; Zhang Y; Ojima I; Shroyer KR
    PLoS One; 2013; 8(9):e69884. PubMed ID: 24086245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model.
    Ahmad G; Mackenzie GG; Egan J; Amiji MM
    Mol Cancer Ther; 2019 Nov; 18(11):1961-1972. PubMed ID: 31439714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low-density lipoprotein docosahexaenoic acid nanoparticles on cancer stem cells isolated from human hepatoma cell lines.
    Yang J; Gong Y; Sontag DP; Corbin I; Minuk GY
    Mol Biol Rep; 2018 Oct; 45(5):1023-1036. PubMed ID: 30069818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
    Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
    Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma.
    Dubrovska A; Elliott J; Salamone RJ; Kim S; Aimone LJ; Walker JR; Watson J; Sauveur-Michel M; Garcia-Echeverria C; Cho CY; Reddy VA; Schultz PG
    Clin Cancer Res; 2010 Dec; 16(23):5692-702. PubMed ID: 21138868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells.
    Xie J; Mølck C; Paquet-Fifield S; Butler L; ; Sloan E; Ventura S; Hollande F
    Oncotarget; 2016 Jul; 7(28):44492-44504. PubMed ID: 27283984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.
    Yuan H; Guo H; Luan X; He M; Li F; Burnett J; Truchan N; Sun D
    Mol Pharm; 2020 Jul; 17(7):2275-2286. PubMed ID: 32485107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.
    Botchkina GI; Zuniga ES; Das M; Wang Y; Wang H; Zhu S; Savitt AG; Rowehl RA; Leyfman Y; Ju J; Shroyer K; Ojima I
    Mol Cancer; 2010 Jul; 9():192. PubMed ID: 20630067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells.
    Shimada K; Anai S; Fujii T; Tanaka N; Fujimoto K; Konishi N
    J Pathol; 2013 Dec; 231(4):495-504. PubMed ID: 24549646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells.
    Lanna EG; Siqueira RP; Machado MGC; de Souza A; Trindade IC; Branquinho RT; Mosqueira VCF
    Biomed Pharmacother; 2021 Feb; 134():111114. PubMed ID: 33352447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
    Sam MR; Ahangar P; Nejati V; Habibian R
    Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.
    Zu Y; Hu Y; Yu X; Jiang S
    Anticancer Agents Med Chem; 2017; 17(4):542-551. PubMed ID: 27539313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells.
    Rao W; Wang H; Han J; Zhao S; Dumbleton J; Agarwal P; Zhang W; Zhao G; Yu J; Zynger DL; Lu X; He X
    ACS Nano; 2015 Jun; 9(6):5725-40. PubMed ID: 26004286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Solid Lipid Nanoparticle Formulation on the Bioavailability of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine After Oral Administration.
    Valdes SA; Alzhrani RF; Lansakara-P DSP; Cui Z
    AAPS PharmSciTech; 2020 Jan; 21(3):77. PubMed ID: 31970527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of coffee oil-algae oil-based nanoemulsions and the study of their inhibition effect on UVA-induced skin damage in mice and melanoma cell growth.
    Yang CC; Hung CF; Chen BH
    Int J Nanomedicine; 2017; 12():6559-6580. PubMed ID: 28919754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
    Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells.
    Chrastina A; Baron VT; Abedinpour P; Rondeau G; Welsh J; Borgström P
    Biomed Res Int; 2018; 2018():9035452. PubMed ID: 30534567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.